Skip to content
value.today

OrthoAccel Technologies, Inc.

🇺🇸 Houston, Texas, USAHealth CareFounded 2006
Total raised
$46 M
7 rounds on record
Latest round
$5 M
Jan 2017
First round on record
Jul 2009
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of OrthoAccel Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2017$5 MNo. 7$2 to $10 million

OrthoAccel Technologies, Inc.: Raise no. 7, Jan 2017

Investors in this round

6 investors had bought by the notice of Jan 20, 2017: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $18 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$100,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff C. Layton · Executive Officer
  • Kelly C. Enos · Executive Officer
  • Brian R. Smith · Director
  • John C. McCormick · Director
  • Len C. Hedge · Director
  • Todd C. Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kelly Enos, Chief Financial Officer, by Eric Hoffmann, Attorney-in-Fact. Source: SEC Form D, newest notice filed Jan 20, 2017. Read the notice at the SEC.

equity, optionsSEC
Feb 2016$12 MNo. 6$10 to $50 million

OrthoAccel Technologies, Inc.: Raise no. 6, Feb 2016

Investors in this round

11 investors had bought by the notice of May 12, 2016: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $12 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff C. Layton · Executive Officer
  • Kelly C. Enos · Executive Officer
  • Mike K. Lowe · Executive Officer, Director
  • Brian R. Smith · Director
  • John C. McCormick · Director
  • Len C. Hedge · Director
  • Todd C. Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kelly Enos, Chief Financial Officer, by Eunice Song, Attorney-in-Fact. Source: SEC Form D and 1 amendment, newest notice filed May 12, 2016. Read the notice at the SEC.

equitySEC
Nov 2014$5 MNo. 5$2 to $10 million

OrthoAccel Technologies, Inc.: Raise no. 5, Nov 2014

Investors in this round

20 investors had bought by the notice of Dec 22, 2014: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff C. Layton · Executive Officer
  • Kelly C. Enos · Executive Officer
  • Michael K Lowe · Executive Officer, Director
  • Brian R. Smith · Director
  • John C. McCormick · Director
  • Todd C. Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kelly Enos, Chief Financial Officer, by Channah Rose, Attorney-in-Fact. Source: SEC Form D, newest notice filed Dec 22, 2014. Read the notice at the SEC.

equitySEC
Jan 2014$5 MNo. 4$2 to $10 million

OrthoAccel Technologies, Inc.: Raise no. 4, Jan 2014

Investors in this round

18 investors had bought by the notice of Jan 23, 2014: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff C. Layton · Executive Officer
  • Michael K. Lowe · Executive Officer, Director
  • Pamela C. Westbrook · Executive Officer
  • Bill C. Ryan · Director
  • Brian R. Smith · Director
  • John C. McCormick · Director
  • Todd C. Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Pamela Westbrook, Chief Financial Officer, by Channah Rose, Attorney-in-Fact. Source: SEC Form D, newest notice filed Jan 23, 2014. Read the notice at the SEC.

equitySEC
Apr 2012$13 MNo. 3$10 to $50 million

OrthoAccel Technologies, Inc.: Raise no. 3, Apr 2012

Investors in this round

18 investors had bought by the notice of May 29, 2013: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $13 M offered
Smallest investment taken
$750
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael K. Lowe · Executive Officer, Director
  • Pamela C. Westbrook · Executive Officer
  • Bill C. Ryan · Director
  • Brian R. Smith · Director
  • John C. McCormick · Director
  • Todd C. Cooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Pamela Westbrook, Chief Financial Officer, by Channah Rose, Attorney-in-Fact. Source: SEC Form D and 1 amendment, newest notice filed May 29, 2013. Read the notice at the SEC.

equitySEC
Jul 2010$5 MNo. 2$2 to $10 million

OrthoAccel Technologies, Inc.: Raise no. 2, Jul 2010

Investors in this round

29 investors had bought by the notice of Aug 30, 2010: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered; $1 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael K. Lowe · Executive Officer, Director
  • Pamela R. Westbrook · Executive Officer
  • Brian R. Smith · Director
  • Linda B. Spain · Director
  • Steve R. Banks · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds used for working capital including ordinary course executive compensation.”

Signed by Michael K. Lowe, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Aug 30, 2010. Read the notice at the SEC.

equitySEC
Jul 2009$2 MNo. 1$2 to $10 million

OrthoAccel Technologies, Inc.: Raise no. 1, Jul 2009

Investors in this round

14 investors had bought by the notice of Dec 22, 2009: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael K. Lowe · Executive Officer
  • Brian K. Smith · Director
  • Linda K. Spain · Director
  • Steve K. Banks · Director
  • William K. Bryan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, including ordinary course salaries of management.”

Signed by Michael K. Lowe, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Dec 22, 2009. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • OrthoAccel Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2017).

    SEC Form D · Jan 2017

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2017

That is all the official record says: OrthoAccel Technologies, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of OrthoAccel Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 29 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by OrthoAccel Technologies, Inc.
NameRoleNamed in
Jeff C. LaytonExecutive officerJan 2017
Kelly C. EnosExecutive officerJan 2017
Mike K. LoweExecutive officerMay 2016
Michael K LoweExecutive officerDec 2014
Michael K. LoweExecutive officerJan 2014
Pamela C. WestbrookExecutive officerJan 2014
Andrew D. LaymanExecutive officerApr 2012
Pamela R. WestbrookExecutive officerAug 2010
Brian R. SmithDirectorJan 2017
John C. McCormickDirectorJan 2017
Len C. HedgeDirectorJan 2017
Todd C. CooperDirectorJan 2017
Mike K. LoweDirectorMay 2016
Michael K LoweDirectorDec 2014
Bill C. RyanDirectorJan 2014
Michael K. LoweDirectorJan 2014
Linda B. SpainDirectorApr 2012
Todd B. CooperDirectorApr 2012
Steve R. BanksDirectorAug 2010
Brian K. SmithDirectorDec 2009
Linda K. SpainDirectorDec 2009
Steve K. BanksDirectorDec 2009
William K. BryanDirectorDec 2009
Brian SmithDirectorAug 2009
Linda SpainDirectorAug 2009
Steve BanksDirectorAug 2009
William BryanDirectorAug 2009